Case Report
Accepted on 24 Jan 2025
Diagnosis and Treatment of Thyroblastoma: A Case Report and Review of Literature
in Head and Neck Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1467631
Type at least 3 characters
1,225 articles
Articles
Clinical Trial
Published on 24 Jan 2025
Benefit from regular versus leakage-related exchange of voice prostheses in patients post-laryngectomy considering complication rates and patient satisfaction feedback—a randomized case−controlled trial
in Head and Neck Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1468955
- 192 views
Original Research
Published on 24 Jan 2025
Disulfidptosis-related gene SLC3A2: a novel prognostic biomarker in nasopharyngeal carcinoma and head and neck squamous cell carcinoma
in Head and Neck Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1451034
- 190 views
Case Report
Accepted on 22 Jan 2025
Late-Onset and Relapsed Cytokine Release Syndrome after Nivolumab Treatment in a Patient with Head and Neck Squamous Cell Carcinoma: A Case Report
in Head and Neck Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1508682
Systematic Review
Accepted on 20 Jan 2025
Risk prediction models for dysphagia after radiotherapy among patients with head and neck cancer: A systematic review and meta-analysis
in Head and Neck Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1502404
Original Research
Accepted on 17 Jan 2025
Expression and Prognostic Significance of the m6A RNA Methylation Regulator HNRNPC in HNSCC
in Head and Neck Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1516867
Original Research
Published on 17 Jan 2025
The application of a clinical-multimodal ultrasound radiomics model for predicting cervical lymph node metastasis of thyroid papillary carcinoma
in Head and Neck Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1507953
- 157 views
Original Research
Published on 17 Jan 2025
Retrospective analysis of 1539 nasopharyngeal carcinoma cases: chemotherapy should not be excluded for non-Asian patients with T1-2N1M0 stage
in Head and Neck Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1529136
- 197 views
Editorial
Published on 17 Jan 2025
Editorial: The role of the microbiome in head and neck cancer
in Head and Neck Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1545067
- 147 views
Original Research
Published on 17 Jan 2025
Major and minor perineural invasion in salivary gland cancer
in Head and Neck Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1466196
- 222 views
Original Research
Accepted on 16 Jan 2025
Hypovitaminosis D in Patients with Oral Leukoplakia: Insights from a Case-Control Study
in Head and Neck Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1522726
Case Report
Published on 16 Jan 2025
Case report: Relapse of intrathyroidal parathyroid carcinoma in a patient with novel variants in MET and CDKN1C genes
in Head and Neck Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1441083
- 238 views
Mini Review
Published on 16 Jan 2025
Exosomes in oral squamous cell carcinoma: functions, challenges, and potential applications
in Head and Neck Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1502283
- 465 views
Original Research
Accepted on 14 Jan 2025
Osteoradionecrosis In Osseous Free Flaps After Maxillofacial Reconstruction: A Single-Center Experience
in Head and Neck Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1527149
Original Research
Accepted on 13 Jan 2025
Antiangiogenic therapy with recombinant human endostatin may improve blood perfusion of cervical node with necrosis in nasopharyngeal carcinoma patients: A preliminary study by using contrast-enhanced ultrasound
in Head and Neck Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1521762
Original Research
Published on 13 Jan 2025
Brucea javanica oil inhibited the proliferation, migration, and invasion of oral squamous carcinoma by regulated the MTFR2 pathway
in Head and Neck Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1477293
- 236 views